November 24, 2020 3:08 am by UroLift New Findings Show UroLift System Same-Day Outpatient Procedure Demonstrates Symptom Improvement for Benign Prostatic Hyperplasia
WAYNE, Pa.— November 19, 2020 – Teleflex Incorporated (NYSE: TFX) today announced the results of four studies that were accepted at the ICS 2020 Annual Meeting – Online reinforcing the safety and efficacy of the UroLift® System for the treatment of benign prostatic hyperplasia (BPH).... Read More
July 22, 2020 2:35 am by UroLift Data Presented at European Association of Urology Highlights Safety and Versatility of the Minimally Invasive UroLift System in a Real-World Setting
... Read More
July 2, 2020 3:49 am by UroLift Data Shows Minimally Invasive Treatment Provides Rapid Symptom Relief, Allowing Men to Return to Daily Activities Quickly
WAYNE, Pa.— June 22,... Read More
May 19, 2020 8:44 am by UroLift Data Presented at American Urological Association 2020 Virtual Experience Highlight Benefits and Superior Sexual Function* Preservation of the Minimally Invasive Treatment for Patients with Enlarged Prostate
WAYNE,... Read More
April 17, 2020 1:34 am by UroLift The Teleflex mission to improve the health and quality of people’s lives has taken on a new meaning during the COVID‑19 pandemic.... Read More
January 8, 2020 2:23 am by UroLift January 7, 2020
Minimally Invasive Procedure Now Available to Hundreds of Thousands More Men with Enlarged Prostate, Providing Safe and Effective Symptom Relief.... Read More
September 16, 2019 7:46 am by UroLift Minimally Invasive Treatment Options for BPH Remain Critical Due to Shortcomings of Surgery and Medication
WAYNE, Pa. –Sept. 16, 2019 – Teleflex Incorporated (NYSE: TFX) today announced the publication of an article showcasing the effectiveness and overall benefits of the minimally invasive UroLift® System treatment for patients with benign prostatic hyperplasia (BPH).... Read More
July 18, 2019 3:10 am by UroLift Results from Multi-Center Study Support the Application of Minimally Invasive Treatment for Broader BPH Population
WAYNE, Pa. – July 9,... Read More
July 12, 2019 9:13 am by UroLift The UroLift® System for the treatment of Benign Prostatic Hyperplasia (BPH) was the subject of three presentations at the Glasgow, Scotland-held urology event: a study men with acute urinary retention;... Read More
January 8, 2019 5:58 am by UroLift PLEASANTON, Calif. – December 14, 2018 – NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology,... Read More
US
AU
UK
